Dissecting molecular events in thyroid neoplasia provides evidence for distinct evolution of follicular thyroid adenoma and carcinoma

American Journal of Pathology

Volumn 179, Issue 6, 2011, Pages 3066-3074

  Krause, Kerstin ^a   Prawitt, Susanne ^a   Eszlinger, Markus ^a   Ihling, Christian ^b   Sinz, Andrea ^b   Schierle, Katrin ^a   Gimm, Oliver ^b   Dralle, Henning ^b   Steinert, Frank ^c   Sheu, Sien Yi ^d   Schmid, Kurt W ^d   Fuhrer, Dagmar ^d  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^c Centre for Minimally Invasive and Laparoscopic Surgery   (Germany)

^d UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

6 PHOSPHOGLUCONOLACTONASE; AMYLOID BETA A4 PROTEIN; AMYLOID BETA PROTEIN; ATM PROTEIN; CALVASCULIN; CATHEPSIN B; CHECKPOINT KINASE 2; CYCLIN E; DJ 1 PROTEIN; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN BETA1; HISTONE H2AX; MACROPHAGE CAPPING PROTEIN; MESSENGER RNA; NUCLEOSIDE DIPHOSPHATE KINASE A; PEROXIREDOXIN 6; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOPROTEIN PHOSPHATASE 2A; PHOSPHOPROTEIN PHOSPHATASE INHIBITOR; PROTEASOME ACTIVATOR COMPLEX SUBUNIT 1; PROTEIN; PROTEIN P53; PROTEIN SET; RAS PROTEIN; RETINOBLASTOMA PROTEIN; THIOREDOXIN; TRANSCRIPTION FACTOR E2F1; TRANSCRIPTION FACTOR PAX8; TUMOR PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; DNA DAMAGE; GENE ACTIVATION; GENE EXPRESSION; GENE MUTATION; GENOMIC INSTABILITY; HUMAN; HUMAN TISSUE; MALIGNANT TRANSFORMATION; MOLECULAR INTERACTION; MUTATION RATE; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; THYROID ADENOMA; THYROID FOLLICULAR ADENOMA; THYROID FOLLICULAR CARCINOMA; THYROID NODULE; UPREGULATION;

ADENOMA; DNA DAMAGE; GENE REARRANGEMENT; GENES, RAS; GENOMIC INSTABILITY; HUMANS; MUTATION RATE; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PAIRED BOX TRANSCRIPTION FACTORS; POINT MUTATION; PPAR GAMMA; PROTEOMICS; THYROID NEOPLASMS; THYROID NODULE; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 81255201252     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2011.08.033     Document Type: Article

References (43)

1. A. Al Ghuzlan, B. Caillou, and M. Schlumberger Galectin-3 for indeterminate thyroid cytology Lancet Oncol 9 2008 508 510 (Pubitemid 351722577)
2. A. Bartolazzi, A. Gasbarri, M. Papotti, G. Bussolati, T. Lucante, A. Khan, H. Inohara, F. Marandino, F. Orlandi, F. Nardi, A. Vecchione, R. Tecce, and O. Larsson Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions Lancet 357 2001 1644 1650 (Pubitemid 32568236)
3. A. Bartolazzi, F. Orlandi, E. Saggiorato, M. Volante, F. Arecco, R. Rossetto, N. Palestini, E. Ghigo, M. Papotti, G. Bussolati, M.P. Martegani, F. Pantellini, A. Carpi, M.R. Giovagnoli, S. Monti, V. Toscano, S. Sciacchitano, G.M. Pennelli, C. Mian, M.R. Pelizzo, M. Rugge, G. Troncone, L. Palombini, G. Chiappetta, G. Botti, A. Vecchione, and R. Bellocco Galectin-3-expression analysis in the surgical selection of follicular thyroid nodules with indeterminate fine-needle aspiration cytology: a prospective multicentre study Lancet Oncol 9 2008 543 549
4. J. Bartkova, Z. Horejsi, K. Koed, A. Kramer, F. Tort, K. Zieger, P. Guldberg, M. Sehested, J.M. Nesland, C. Lukas, T. Orntoft, J. Lukas, and J. Bartek DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis Nature 434 2005 864 870 (Pubitemid 40558993)
5. V.G. Gorgoulis, L.V. Vassiliou, P. Karakaidos, P. Zacharatos, A. Kotsinas, T. Liloglou, M. Venere, R.A. DiTullio Jr., N.G. Kastrinakis, B. Levy, D. Kletsas, A. Yoneta, M. Herlyn, C. Kittas, and T.D. Halazonetis Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions Nature 434 2005 907 913 (Pubitemid 40559004)
6. T.D. Halazonetis, V.G. Gorgoulis, and J. Bartek An oncogene-induced DNA damage model for cancer development Science 319 2008 1352 1355 (Pubitemid 351354863)
7. J.P. Reddy, S. Peddibhotla, W. Bu, J. Zhao, S. Haricharan, Y.C. Du, K. Podsypanina, J.M. Rosen, L.A. Donehower, and Y. Li Defining the ATM-mediated barrier to tumorigenesis in somatic mammary cells following ErbB2 activation Proc Natl Acad Sci U S A 107 2010 3728 3733
8. K.W. Schmid Molecular pathology of thyroid tumors [in French] Pathologe 31 Suppl 2 2010 229 233
9. K. Krause, M. Eszlinger, O. Gimm, S. Karger, C. Engelhardt, H. Dralle, and D. Fuhrer TFF3-based candidate gene discrimination of benign and malignant thyroid tumors in a region with borderline iodine deficiency J Clin Endocrinol Metab 93 2008 1390 1393 (Pubitemid 351519738)
10. V. Vasko, M. Ferrand, J. Di Cristofaro, P. Carayon, J.F. Henry, and C. De Micco Specific pattern of RAS oncogene mutations in follicular thyroid tumors J Clin Endocrinol Metab 88 2003 2745 2752 (Pubitemid 36724451)
11. G. Garcia-Rostan, A.M. Costa, I. Pereira-Castro, G. Salvatore, R. Hernandez, M.J. Hermsem, A. Herrero, A. Fusco, J. Cameselle-Teijeiro, and M. Santoro Mutation of the PIK3CA gene in anaplastic thyroid cancer Cancer Res 65 2005 10199 10207 (Pubitemid 41743711)
12. S. Karger, K. Berger, M. Eszlinger, A. Tannapfel, H. Dralle, R. Paschke, and D. Fuhrer Evaluation of peroxisome proliferator-activated receptor-gamma expression in benign and malignant thyroid pathologies Dtsch Med Wochenschr 15 2005 997 1003 (Pubitemid 41475709)
13. D. Fuhrer, A. Tannapfel, O. Sabri, P. Lamesch, and R. Paschke Two somatic TSH receptor mutations in a patient with toxic metastasising follicular thyroid carcinoma and non-functional lung metastases Endocr Relat Cancer 10 2003 591 600 (Pubitemid 38094893)
14. T.G. Kroll, P. Sarraf, L. Pecciarini, C.J. Chen, E. Mueller, B.M. Spiegelman, and J.A. Fletcher PAX8-PPARgamma1 fusion oncogene in human thyroid carcinoma [corrected] Science 289 2000 1357 1360 (Pubitemid 30656054)
15. K. Krause, A. Schierhorn, A. Sinz, J.D. Wissmann, A.G. Beck-Sickinger, R. Paschke, and D. Fuhrer Towards the application of proteomics to human thyroid tissue Dtsch Med Wochenschr 16 2006 1131 1143 (Pubitemid 44864488)
16. A. Shevchenko, H. Tomas, J. Havlis, J.V. Olsen, and M. Mann In-gel digestion for mass spectrometric characterization of proteins and proteomes Nat Protoc 1 2006 2856 2860
17. A. Sturn, J. Quackenbush, and Z. Trajanoski Genesis: cluster analysis of microarray data Bioinformatics 18 2002 207 208 (Pubitemid 34145055)
18. K. Krause, S. Karger, A. Schierhorn, S. Poncin, M.C. Many, and D. Fuhrer Proteomic profiling of cold thyroid nodules Endocrinology 148 2007 1754 1763 (Pubitemid 46457138)
19. J. Bartek, J. Bartkova, and J. Lukas DNA damage signalling guards against activated oncogenes and tumour progression Oncogene 26 2007 7773 7779 (Pubitemid 350242463)
20. K. Krause, B. Jessnitzer, and D. Fuhrer Proteomics in thyroid tumor research J Clin Endocrinol Metab 94 2009 2717 2724
21. Y.C. Hsu, J.J. Chern, Y. Cai, M. Liu, and K.W. Choi Drosophila TCTP is essential for growth and proliferation through regulation of dRheb GTPase Nature 445 2007 785 788 (Pubitemid 46279709)
22. F. Li, D. Zhang, and K. Fujise Characterization of fortilin, a novel antiapoptotic protein J Biol Chem 276 2001 47542 47549
23. L. Susini, S. Besse, D. Duflaut, A. Lespagnol, C. Beekman, G. Fiucci, A.R. Atkinson, D. Busso, P. Poussin, J.C. Marine, J.C. Martinou, J. Cavarelli, D. Moras, R. Amson, and A. Telerman TCTP protects from apoptotic cell death by antagonizing bax function Cell Death Differ 15 2008 1211 1220 (Pubitemid 351984751)
24. Q. Ma, Y. Geng, W. Xu, Y. Wu, F. He, W. Shu, M. Huang, H. Du, and M. Li The role of translationally controlled tumor protein in tumor growth and metastasis of colon adenocarcinoma cells J Proteome Res 9 2010 40 49
25. G.L. Wang, P. Iakova, M. Wilde, S. Awad, and N.A. Timchenko Liver tumors escape negative control of proliferation via PI3K/Akt-mediated block of C/EBP alpha growth inhibitory activity Genes Dev 18 2004 912 925 (Pubitemid 38529660)
26. K. Krohn, D. Fuhrer, H.P. Holzapfel, and R. Paschke Clonal origin of toxic thyroid nodules with constitutively activating thyrotropin receptor mutations J Clin Endocrinol Metab 83 1998 130 134 (Pubitemid 28498323)
27. K. Krohn, A. Reske, F. Ackermann, A. Muller, and R. Paschke Ras mutations are rare in solitary cold and toxic thyroid nodules Clin Endocrinol (Oxf) 55 2001 241 248 (Pubitemid 32868590)
28. Y. Samuels, Z. Wang, A. Bardelli, N. Silliman, J. Ptak, S. Szabo, H. Yan, A. Gazdar, S.M. Powell, G.J. Riggins, J.K. Willson, S. Markowitz, K.W. Kinzler, B. Vogelstein, and V.E. Velculescu High frequency of mutations of the PIK3CA gene in human cancers Science 304 2004 554 (Pubitemid 38541907)
29. I.G. Campbell, S.E. Russell, D.Y. Choong, K.G. Montgomery, M.L. Ciavarella, C.S. Hooi, B.E. Cristiano, R.B. Pearson, and W.A. Phillips Mutation of the PIK3CA gene in ovarian and breast cancer Cancer Res 64 2004 7678 7681 (Pubitemid 39446895)
30. F. Tort, J. Bartkova, M. Sehested, T. Orntoft, J. Lukas, and J. Bartek Retinoblastoma pathway defects show differential ability to activate the constitutive DNA damage response in human tumorigenesis Cancer Res 66 2006 10258 10263 (Pubitemid 44799741)
31. C.H. Spruck, K.A. Won, and S.I. Reed Deregulated cyclin E induces chromosome instability Nature 401 1999 297 300
32. N. Mailand, J. Falck, C. Lukas, R.G. Syljuasen, M. Welcker, J. Bartek, and J. Lukas Rapid destruction of human Cdc25A in response to DNA damage Science 288 2000 1425 1429 (Pubitemid 30366329)
33. M. Li, A. Makkinje, and Z. Damuni The myeloid leukemia-associated protein SET is a potent inhibitor of protein phosphatase 2A J Biol Chem 271 1996 11059 11062 (Pubitemid 26155931)
34. D. Perrotti, and P. Neviani ReSETting PP2A tumour suppressor activity in blast crisis and imatinib-resistant chronic myelogenous leukaemia Br J Cancer 95 2006 775 781 (Pubitemid 44500626)
35. A.H. Schonthal Role of serine/threonine protein phosphatase 2A in cancer Cancer Lett 170 2001 1 13 (Pubitemid 32607654)
36. T. Gao, F. Furnari, and A.C. Newton PHLPP: a phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth Mol Cell 18 2005 13 24 (Pubitemid 40444644)
37. J.E. Paes, and M.D. Ringel Dysregulation of the phosphatidylinositol 3-kinase pathway in thyroid neoplasia Endocrinol Metab Clin North Am 37 2008 375 -3ix
38. K. Hong, L. Lou, S. Gupta, F. Ribeiro-Neto, and D.L. Altschuler A novel Epac-Rap-PP2A signaling module controls cAMP-dependent Akt regulation J Biol Chem 283 2008 23129 23138
39. S.W. Al Murrani, J.R. Woodgett, and Z. Damuni Expression of I2PP2A, an inhibitor of protein phosphatase 2A, induces c-Jun and AP-1 activity Biochem J 341 pt 2 1999 293 298 (Pubitemid 29373652)
40. M. Tuynder, L. Susini, S. Prieur, S. Besse, G. Fiucci, R. Amson, and A. Telerman Biological models and genes of tumor reversion: cellular reprogramming through tpt1/TCTP and SIAH-1 Proc Natl Acad Sci U S A 99 2002 14976 14981 (Pubitemid 35334595)
41. D. Nagakubo, T. Taira, H. Kitaura, M. Ikeda, K. Tamai, S.M. Iguchi-Ariga, and H. Ariga DJ-1, a novel oncogene which transforms mouse NIH3T3 cells in cooperation with ras Biochem Biophys Res Commun 231 1997 509 513 (Pubitemid 27214343)
42. A. Mitsumoto, and Y. Nakagawa DJ-1 is an indicator for endogenous reactive oxygen species elicited by endotoxin Free Radic Res 35 2001 885 893 (Pubitemid 34065677)
43. T. Taira, Y. Saito, T. Niki, S.M. Iguchi-Ariga, K. Takahashi, and H. Ariga DJ-1 has a role in antioxidative stress to prevent cell death EMBO Rep 5 2004 213 218 (Pubitemid 38401204)